View Author
dai: 070659796
scopus: 7101668722
Stoter, G.
(Gerrit Stoter)Supervisor (promotor) of 18 dissertations
patient cancer study treatment paclitaxel level cisplatin concentration resistance tumor plasma expression response protein pharmacokinetic cpt -11 sample blood -11 activity effect chemotherapy result lymphocytes yeast infusion administration phase change range value table group carcinoma antibody baseline depression analysis sensitivity -12 number 8 weeks cancer patients therapy metabolite sn -38 ratio production cerevisiae doxorubicin cycle adherence serum breast irinotecan agent biomarker -38 assay control receptor course parameter oncol disease toxicity strain cytokine antigen sparreboom melanoma correlation lactone breast cancer trial point month symptom 9- ac progression
10 Most Recent Publications
|
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-a therapy
(Article)
Fekkes, D. Gool, A.R. van Bannink, M. Sleijfer, S. Kruit, W.H.J. Holt, B. van der Eggermont, A.M.M. Hengeveld, M.W. Stoter, G. |
2009-10-01
|
|
A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal
(Article)
Oldenmenger, W.H. Smitt, P.A. Dooren, S. van Stoter, G. Rijt, C.C.D. van der |
2009-05-01
|
|
Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-α: Course and relationship with psychiatric status
(Article)
Gool, A.R. van Verkerk, R. Hengeveld, M.W. Fekkes, D. Bannink, M. Sleijfer, S. Kruit, W.H.J. Holt, B. van der Scharpé, S. Eggermont, A.M.M. Stoter, G. |
2008-10-01
|
|
Serum proteomic patterns for ovarian cancer monitoring
(Article)
Helleman, J. Vlies, D. van der Jansen, M.P.H.M. Luider, T.M. Burger, C.W. Stoter, G. Berns, P.M.J.J. |
2008-09-01
|
|
Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-α in patients with renal cell carcinoma
(Article)
Gool, A.R. van Verkerk, R. Hengeveld, M.W. Fekkes, D. Sleijfer, S. Bannink, M. Kruit, W.H.J. Holt, B. van der Scharpé, S. Eggermont, A.M.M. Stoter, G. |
2008-05-01
|
|
Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated
(Article)
Bannink, M. Kruit, W.H.J. Gool, A.R. van Sleijfer, S. Holt, B. van der Eggermont, A.M.M. Stoter, G. Hengeveld, M.W. |
2008-01-01
|
|
Analgesic Adherence Measurement in Cancer Patients: Comparison Between Electronic Monitoring and Diary
(Article)
Oldenmenger, W.H. Echteld, M.A. Wit, R. de Smitt, P.A. Stronks, D.L. Stoter, G. Rijt, C.C.D. van der |
2007-12-01
|
|
Interferon-α influences tryptophan metabolism without inducing psychiatric side effects
(Article)
Bannink, M. Fekkes, D. Gool, A.R. van Kruit, W.H.J. Sleijfer, S. Holt, B. van der Eggermont, A.M.M. Stoter, G. Hengeveld, M.W. |
2007-10-01
|
|
Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients
(Article)
Fekkes, D. Bannink, M. Kruit, W.H.J. Gool, A.R. van Mulder, P.G.H. Sleijfer, S. Eggermont, A.M.M. Stoter, G. |
2007-01-01
|
|
Mismatch repair and treatment resistance in ovarian cancer.
(Article)
Helleman, J. Staveren, I.L. van Dinjens, W.N.M. Kuijk, P.F. van Ruigrok-Ritstier, K. Ewing, P.C. Burg, M.E.L. van der Stoter, G. Berns, P.M.J.J. |
2006-07-31
|
